Home > News > NanoCure Changes Name to Avidimer Therapeutics
May 17th, 2005
NanoCure Changes Name to Avidimer Therapeutics
Abstract:
James R. Baker, Jr., M.D., Avidimer's chairman and chief scientific officer, commented, "The name Avidimer Therapeutics refers to our focus on cell-specific targeting of therapeutics and diagnostics through the use of novel branch-like polymers known as dendrimers, which avidly target diseased cells and have the potential to diagnose and treat cancer and other diseases more effectively and completely than current diagnostics and therapeutics. Their small size (less than 5nm) enables them to escape the blood stream through vascular pores, selectively target and treat tumor cells, and be cleared rapidly through the kidney. Preclinical studies have demonstrated the impressive ability of dendrimers to target diseased cells in the body."
Source:
genengnews.com
Bookmark:
Nanomedicine
Nanotechnology could help fight diabetes: Injectable nanogel can monitor blood-sugar levels and secrete insulin when needed May 16th, 2013
Nanobiotix Revenue for the 1st quarter of 2013 May 15th, 2013
Pitt Chemists Demonstrate Nanoscale Alloys So Bright They Could Have Potential Medical Applications: “Think about a particle that will not only help researchers detect cancer sooner but be used to treat the tumor, too.” May 15th, 2013
Using clay to grow bone: Researchers use synthetic silicate to stimulate stem cells into bone cells May 15th, 2013
Announcements
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
NanoInk, Inc. Assets To Be Sold May 18th, 2013
NIA Public Briefing: Nanotechnology and the Council of Europe May 17th, 2013
Scientists capture first direct proof of Hofstadter butterfly effect May 17th, 2013